Additional file 1 of Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritisMaarit Tarkiainen, Pirjo Tynjälä, Paula Vähäsalo, Kristiina Aalto, Liisa Kröger, Katariina Rebane, Pekka Lahdenne & Janne Martikainen
Additional file 1. Resource use during the first year treatment of Juvenile Idiopathic Arthritis.
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.